Ushiku, Japan

Yukio Hattori

This inventor holds 6 USPTO granted patents. Top assignee: Kowa Company Limited. Active years: 2001-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yukio Hattori. Retrieved from https://idiyas.com/inventor/yukio-hattori-75la3usb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 9.9

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2001-2004

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Journey of Yukio Hattori

Introduction

Yukio Hattori, an accomplished inventor based in Ushiku, Japan, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of six patents, Hattori's work focuses on developing novel compounds that hold promise for medical applications.

Latest Patents

Among his latest inventions are two noteworthy patents: the "Diamide compound and medicine containing the same" and the "Cyclic amide compound." These innovations showcase his dedication to advancing medicinal chemistry and improving healthcare solutions.

Career Highlights

Hattori is currently associated with Kowa Company Limited, a prominent player in the pharmaceutical industry. His role within this esteemed organization allows him to leverage his expertise and contribute to cutting-edge research and product development.

Collaborations

In his professional journey, Hattori has collaborated with talented individuals such as Hiroyuki Ishiwata and Mototsugu Kabeya. These partnerships have fostered a creative environment, leading to innovative breakthroughs that benefit the scientific community.

Conclusion

Yukio Hattori's work exemplifies the spirit of innovation through his commitment to developing essential compounds for medical use. As he continues his journey, his contributions not only enhance the capabilities of Kowa Company Limited but also reinforce the importance of collaboration in achieving groundbreaking advancements in the field of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…